Submitted by Anonymous (not verified) on 13 November 2023 - 9:56
Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Arthritis, Rheumatoid, Date of authorisation: 22/03/2017, Date of refusal: 25/04/2013, Revision: 28, Status: Authorised
Source: